Full Text View
Tabular View
No Study Results Posted
Related Studies
Medical and Economical Impact of IGRAs Diagnosis of Latent Tuberculosis in HIV-Infected Patients (IGRAVIH)
This study is not yet open for participant recruitment.
Study NCT00805272   Information provided by Assistance Publique - Hôpitaux de Paris
First Received: December 8, 2008   Last Updated: January 7, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
HIV
Tuberculosis
Latent Tuberculosis Infection
HIV Infections
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
Communicable Diseases
Infection
More general conditions related to this trial
Actinomycetales Infections
Bacterial Infections
Gram-Positive Bacterial Infections
Immune System Diseases
Immunologic Deficiency Syndromes
Lentivirus Infections
Mycobacterium Infections
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Virus Diseases
Interventions listed in this trial
QTF-TB Gold and T-SPOT TB
Sponsors listed in this trial
Assistance Publique - Hôpitaux de Paris


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services